- Home
- TNGX vs ABM Comparison
TNGX vs ABM Comparison
Compare TNGX & ABM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TNGX | ABM |
|---|---|---|
| Founded | 2014 | 1909 |
| Country | United States | United States |
| Employees | N/A | 113000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | TNGX | ABM |
|---|---|---|
| Price | $31.47 | $45.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | $21.78 | ★ $47.80 |
| AVG Volume (30 Days) | ★ 5.5M | 714.5K |
| Earning Date | 05-08-2026 | 06-05-2026 |
| Dividend Yield | N/A | ★ 2.92% |
| EPS Growth | 26.89 | ★ 102.34 |
| EPS | N/A | ★ 1.37 |
| Revenue | $62,384,000.00 | ★ $8,745,900,000.00 |
| Revenue This Year | N/A | $5.97 |
| Revenue Next Year | N/A | $3.45 |
| P/E Ratio | ★ N/A | $32.72 |
| Revenue Growth | ★ 48.29 | 4.62 |
| 52 Week Low | $4.80 | $36.96 |
| 52 Week High | $34.39 | $50.12 |
Technical Indicators
Market Signals| Indicator | TNGX | ABM |
|---|---|---|
| Relative Strength Index (RSI) | 58.74 | 64.46 |
| Support Level | $19.74 | $44.50 |
| Resistance Level | $34.39 | $46.94 |
| Average True Range (ATR) | 2.49 | 1.30 |
| MACD | -0.05 | 0.04 |
| Stochastic Oscillator | 48.50 | 55.62 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About ABM ABM Industries Incorporated
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.